<DOC>
	<DOCNO>NCT00187720</DOCNO>
	<brief_summary>The current study part large multi-investigator grant look pharmacogenetics number membrane transporter . We study individual particular genotype human organic cation transporter , ( hOCT2 ) , test hypothesis genetic variation hOCT2 associate variation renal clearance antidiabetic agent , metformin .</brief_summary>
	<brief_title>Genetic Basis Variation Renal Elimination Metformin</brief_title>
	<detailed_description>The drug , use treatment Type II diabetes , narrow therapeutic range . Its net renal clearance secretion ( i.e. , renal clearance minus filtration clearance ) range approximately 100 ml/min 800ml/min normal , healthy subject . Although many factor may contribute inter-individual variation renal secretory clearance , initial estimate heritability ( great 0.6 ) suggest genetic factor play important role renal secretion metformin . Available evidence support idea hOCT2 primary transporter involve first-step renal secretion metformin , i.e. , uptake blood tubule cell across basolateral membrane . In particular , ( ) hOCT2 primary organic cation transporter basolateral membrane human kidney ; ( b ) metformin interacts translocate hOCT2 heterologous expression system . In recent study , identify four variant ( M165I , A270S , R400C , K432Q ) ethnic-specific allele frequency ≥1 % [ 6 ] alter function study heterologous expression system . In addition , identified common haplotype hOCT2 one haplotype contain non-synonymous cSNP , A270S . We determine whether variability renal secretory clearance model organic cation , metformin , healthy individual associate genetic variation hOCT2 . In particular , determine whether renal clearance metformin differs individual homozygous common haplotype OCT2 ( OCT2*1 ) heterozygous less common haplotype OCT2*3D , identify comprehensive screen ethnically identify DNA sample . We also determine whether individual heterozygous less common OCT2 variant , M165I , R400C K432Q , reduce renal clearance metformin .</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<criteria>Subjects previously participate Study Of Pharmacogenetics In Ethnically Diverse Populations ( SOPHIE ) study . 1840 year old Possess prespecified genotype OCT2 Taking regular medication vitamin . Individuals anemia ( hemoglobin &lt; 12 g/dL ) , elevation liver enzymes higher double respective normal value , elevate creatinine concentration ( male ≥ 1.5 mg/dL , females ≥ 1.4 mg/dL ) Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Healthy Control</keyword>
</DOC>